TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
TCL Archive Presidents’ FY93 Budget Holds NCI To $2 Billion, Gives NIH 5% Increase; Coalition ‘Disapionted’ February 7, 1992
TCL Archive In Brief: ACS to support $2 Billion NCI Budget; NCAB Backs Minority Enhancement Core Supplements February 19, 1988
TCL Archive Institute Of Medicine Report Says Insurers Should Pay Patient Care Costs In Clinical Trials February 24, 1989
TCL Archive In Brief: Increasing Survival Through Adjuvant Therapy Seen As Adding To Cost Of Care October 24, 1975
